Funding Opportunities

LETTER OF INTENT DEADLINE EXTENDED: Monday, September 3, 2018
APPLICATION DEADLINE EXTENDED: Monday, September 17, 2018

• Pilot funding for CANCER-RELATED research with a basic, clinical, prevention & control, behavioral, health services, or epidemiological focus.
• Up to $30,000 award.
• Applications accepted for general cancer-related projects and for special interest projects in adolescent-and-young-adult cancer research.

ELIGIBILITY

The Case CCC is encouraging investigators to submit Letters of Intent (LOI) for Early Phase Clinical Research Support (EPCRS) funding. These in-house funds are available for the conduct of early phase clinical trials of relatively short duration. Priority will be given to trials which are developed jointly between UH and CCF with planned accrual at both institutions.

The proposals are being accepted on a rolling basis subject to availability of funds. 

DEADLINE:  August 17, 2018

The Case Comprehensive Cancer Center is providing seed funding for new collaborative multi-investigator and impactful proposals that will complement the Case CCC Scientific Initiatives and generate key data for larger, nationally competitive grants. Projects must be transformative in nature and focus on Genomics, Drug Discovery, Community and Disparities Research, AYA, Immunotherapy, Women’s Cancers, or Brain Tumors. Investigators should submit ideas that will build new collaborations

DEADLINE: Applications will be accepted on a rolling basis